Vaccination News

The CDC’s vaccine advisory committee on Tuesday voted to recommend Novavax’s two-dose COVID-19 vaccine for adults in the United States.

Last week, the FDA authorized Novavax’s two-dose COVID-19 vaccine, expanding options in the United States.

A third or fourth dose of one of the COVID-19 messenger RNA vaccines offer increased protection among adults during the early omicron wave, according to data from more than 270,000 patients reported Friday in MMWR.

Influenza-like illness conferred increased odds of 30-day stroke in young patients, but vaccination was associated with lower risk compared with non-vaccination, according to data published in Stroke.

The FDA issued an emergency use authorization for Novavax’s two-dose COVID-19 vaccine, making it the fourth COVID-19 vaccine available for use in the United States.

The type of COVID-19 vaccine and the timing of its administration can affect the immune response of pregnant women and their children, data in Nature Communications showed.

More than half of surveyed parents said they were likely to follow the advice of their child’s primary care physician when it came to COVID-19 vaccination, according to results published in Academic Pediatrics.

The Biden administration on Tuesday confirmed that it has had discussions about making second COVID-19 booster shots available to all U.S. adults amid a surge in infections driven by the omicron BA.5 subvariant.

The Moderna COVID-19 mRNA vaccine was more likely to elicit a stronger response in patients with varying degrees of immunosuppression than the Pfizer-BioNTech vaccine, according to data published in JAMA Network Open.

COVID-19 vaccination “fundamentally altered” the pandemic by saving nearly 20 million lives in the first year that vaccines were available, researchers found using a mathematical model.